Tim D. Oliver
Charterhouse Square
London, ENG EC1M6BQ, United Kingdom
London, ENG EC1M6BQ, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
High Frequency Loss of 17q11.2 and Downregulation of the Cancer Metastasis Suppression microRNA miR-193a-3p in Prostate Cancer Bone Metastasis.
Journal: Cancers
Published: January 04, 2026
Reflections: the UK after Brexit.
Journal: International politics (Hague, Netherlands)
Published: April 28, 2023
The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer.
Journal: Frontiers in oncology
Published: October 03, 2022
The Identification of Plasma Exosomal miR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Development by Plasma Exosomal miRNA Sequencing.
Journal: Frontiers in cell and developmental biology
Published: September 03, 2020
Noninvasive Detection of Clinically Significant Prostate Cancer Using Circulating Tumor Cells.
Journal: The Journal of urology
Published: August 08, 2019
The potential of brentuximab vedotin, alone or in combination with current clinical therapies, in the treatment of testicular germ cell tumors.
Journal: American journal of cancer research
Published: February 26, 2019
Identification of low oxygen-tolerating bacteria in prostate secretions of cancer patients and discussion of possible aetiological significance.
Journal: Scientific reports
Published: March 23, 2017
The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 07, 2016
Last Updated: 09/26/2026